Antihyperlipidemic Effects of Red Ginseng, Crataegii Fructus and Their Main Constituents Ginsenoside Rg3 and Ursolic Acid in Mice |
Min, Sung-Won
(College of Pharmacy, Kyung Hee University)
Jung, Sang-Hyun (School of Korean Medicine, Kyung Hee University) Cho, Ki-Ho (School of Korean Medicine, Kyung Hee University) Kim, Dong-Hyun (College of Pharmacy, Kyung Hee University) |
1 | Chang, W. T., Dao, J., Shao, Z. H. (2005). Hawthorn: potential roles in cardiovascular disease. Am. J. Chin. Med. 33, 1-10 DOI ScienceOn |
2 | Davidson, M. H. (2003). Ezetimibe: a novel option for lowering cholesterol. Expert. Rev. Cardiovasc. Ther. 1, 11-21 DOI ScienceOn |
3 | Ballinger, A. (2000). Orlistat in the treatment of obesity. Expert. Opin. Pharmacother. 1, 841-847 DOI ScienceOn |
4 | Carey, M. C., Small, D. M. and Bliss, C. M. (1993). Lipid digestion and absorption. Annu. Rev. Physiol. 45, 651-677 DOI ScienceOn |
5 | Meigs, T. E., Roseman, D. S. and Simoni, R. D. (1996). Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J. Biol. Chem. 271, 7916-7922 DOI |
6 | Thomson, A. B., Schoeller, C., Keelan, M., Smith, L. Clandinin M. T. (1993). Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can. J. Physiol. Pharmacol. 71, 531-555 DOI ScienceOn |
7 | Edwards, P. A., Lemongello, D. and Kane, J. (1980). Properties of purified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and regulation of enzyme activity. J. Biol. Chem. 255, 3715-3725 |
8 | Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W. and Fu, P. C.(1974). Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-475 |
9 | Bae, E. A., Han, M. J., Choo, M. K., Park, S. Y. and Kim, D. H.(2002). Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25, 58-63 DOI ScienceOn |
10 | Edwards, P. A., Lemongello, D. and Fogelman, A. M. (1979). Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Lipid Res. 20, 40-46 |
11 | Endo, A. (1992). The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569-1582 |
12 | Goldstein, J. L., Schrott, H., Hazzard, E., Bierman, E. and Motuski, A. (1973). Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52, 1544-1568 DOI |
13 | Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49, 57-68 DOI |
14 | Heber, D. (2001). Herbs and atherosclerosis. Curr. Atheroscler. Rep. 3, 93-96 DOI |
15 | Ia Cour, B., Molgaard, P., Yi, Z. (1995). Traditional Chinese medicine in treatment of hyperlipidaemia. J. Ethnopharmacol. 46, 125-129 (1995) DOI ScienceOn |
16 | Inoue, M., Wu C.Z., Dou D.Q., Chen Y.J., Ogihara Y. (1999). Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals. Phytomedicine 6, 257-265 DOI ScienceOn |
17 | Thompson Coon J. S. and Ernst E. (2003). Herbs for serum cholesterol reduction: a systematic view. J. Fam. Pract. 52, 468-478 |
18 | Trinh, H. T., Han, S. J., Kim, S. W., Lee, Y. C. and Kim, H. D. (2007). Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J. Microbiol. Biotechnol. 17, 1127-1133 과학기술학회마을 |
19 | Zhou, L., Zuo, Z. and Chow, M. S. (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45, 1345-1359 DOI |
20 | Kusama, H., Nishiyama, M. and Ikeda, S. (1988). Pharmacological investigation of bezafibrate, a hypolipidemic agent (1). Effects of bezafibrate on normal and experimental hyperlipidemia in rats. Folia Pharmacol. Jpn. 92, 175-180 DOI |
21 | White, L. W. and Rudney, H. (1970). Regulation of 3-hydroxy-3-methylglutarate and mevalonate biosynthesis by rat liver homogenates. Effects of fasting, cholesterol feeding, and triton administration. Biochemistry 9, 2725-2731 DOI ScienceOn |
22 | Sardesai V.M. and Mannig J.A., The determination of triglycerides in plasma and tissues. Clin. Chem. 14, 156-158 |
23 | Duhault, J., Boulanger, M., Beregi, L., Sicot, N., Bouvier, F. (1976). 780 SE: a new type of hypolipemic agent. Atherosclerosis, 23, 63-72 DOI |
24 | Espenshade P. J., Hughes A. L. (2007). Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401-427 DOI ScienceOn |
25 | Birari, R. B. and Bhutani, K. K. (2007). Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 12, 879-889 DOI ScienceOn |
26 | Heller, R. A. and Shrewsburg, M. A. (1976). 3-Hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Its purification, properties, and immunochemical studies. J. Biol. Chem. 251, 3815-3822 |
27 | Kim H. Y., Jeong da, M., Jung, H. J., Jung, Y. J., Yokozawa, T. and Choi, J. S. (2008). Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Biol. Pharm. Bull. 31, 73-78 DOI ScienceOn |